BULARREKO MINBIZIA
Hospital Universitario de Basurto
Bilbao, EspañaHospital Universitario de Basurto-ko ikertzaileekin lankidetzan egindako argitalpenak (10)
2024
2023
-
Functional Engagement of the PD-1/PD-L1 Complex But Not PD-L1 Expression Is Highly Predictive of Patient Response to Immunotherapy in Non-Small-Cell Lung Cancer
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 41, Núm. 14, pp. 2561-2570
-
Long-term outcomes of high-risk HR-positive and HER2-negative early breast cancer patients from GEICAM adjuvant studies and El Álamo IV registry
Breast Cancer Research and Treatment, Vol. 201, Núm. 2, pp. 151-159
2022
-
Safety and efficacy of ribociclib plus letrozole in patients with HR+, HER2– advanced breast cancer: Results from the Spanish sub-population of the phase 3b CompLEEment-1 trial
Breast, Vol. 66, pp. 77-84
-
[Translated article] Cytologic Contamination of the Sampling Needle in Endobronchial Ultrasound
Archivos de Bronconeumologia, Vol. 58, Núm. 4, pp. T367-T368
2021
-
Cytologic Contamination of the Sampling Needle in Endobronchial Ultrasound
Archivos de Bronconeumologia
2020
-
The urinary transcriptome as a source of biomarkers for prostate cancer
Cancers, Vol. 12, Núm. 2
2019
-
Survival impact of primary tumor resection in de novo metastatic breast cancer patients (GEICAM/El Alamo Registry)
Scientific Reports, Vol. 9, Núm. 1
2018
-
Clinical and economic impact of the 21-gene recurrence score assay in adjuvant therapy decision making in patients with early-stage breast cancer: Pooled analysis in 4 basque country university hospitals
ClinicoEconomics and Outcomes Research, Vol. 10, pp. 189-199
2016
-
Nab-Paclitaxel in metastatic breast cancer: Defining the best patient profile
Current Cancer Drug Targets, Vol. 16, Núm. 5, pp. 415-428